Milton ParkOn-siteSeniorFull-time
risk-assessmentNov 19, 2026
Develops oncolytic immunotherapies for cancer treatment.
What people who've worked at Replimune say.
Loading reviews…
31
open roles tracked
-14 vs. previous period
Jobs added per day, last 60 days